A phase II evaluation of nivolumab, a fully human antibody against PD-1, in the treatment of persistent or recurrent cervical cancer.Alessandro D. Santin, Michael J. Birrer, Heather A. Lankes et al.|Journal of Clinical Oncology|2018Cited by 11
Integrated indices for sustainable water management in the Guanzhong Basin, ChinaYong Wang, Minjian Chen, Yong Zhao et al.|Journal of Hydrology Regional Studies|2025Cited by 2